CG Oncology, Inc. (CGON) stock
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$78.94−5.84 (-6.89%)
Close on Nov 17, 2026Market cap $7.00BP/E –Yield –
CG Oncology gross margin
Gross margin is gross profit as a percentage of revenue.
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -66.4% | – |
| Q3 FY2025 | Sep 30, 2025 | 5.3% | – |
See a number that looks wrong?